These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37704060)

  • 1. Protective immunization against Enterohemorrhagic Escherichia coli and Shigella dysenteriae Type 1 by chitosan nanoparticle loaded with recombinant chimeric antigens comprising EIT and STX1B-IpaD.
    Mosadegh S; Abtahi H; Amani J; Karizi SZ; Salmanian AH
    Microb Pathog; 2023 Nov; 184():106344. PubMed ID: 37704060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization against Vibrio cholerae, ETEC, and EHEC with chitosan nanoparticle containing LSC chimeric protein.
    Ghaffari Marandi BH; Zolfaghari MR; Kazemi R; Motamedi MJ; Amani J
    Microb Pathog; 2019 Sep; 134():103600. PubMed ID: 31202906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IpaD-loaded N-trimethyl Chitosan Nanoparticles Can Efficiently Protect Guinea Pigs against Shigella flexneri.
    Akbari MR; Saadati M; Honari H; Ghorbani HM
    Iran J Immunol; 2019 Sep; 16(3):212-224. PubMed ID: 31552830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of EHEC infection by chitosan nano-structure coupled with synthetic recombinant antigen.
    Khanifar J; Hosseini RH; Kazemi R; Ramandi MF; Amani J; Salmanian AH
    J Microbiol Methods; 2019 Feb; 157():100-107. PubMed ID: 30633949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Entrapment of HETS recombinant protein onto PLGA and alginate NPs improves the immunogenicity of the protein against E. coli O157:H7.
    Kordbacheh E; Nazarian S; Hajizade A; Farhang A
    Mol Immunol; 2019 Oct; 114():612-619. PubMed ID: 31542606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenic Potency of a Chimeric Protein Comprising InvH and IpaD against Salmonella and Shigella spp.
    Emami Mahmoudabadi FS; Vakili A; Nazarian S; Amani J; Mousavi Gargari SL
    Iran J Allergy Asthma Immunol; 2021 Aug; 20(4):484-493. PubMed ID: 34418902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Gold Nanoparticle Vaccine against Enterohemorrhagic Escherichia coli O157:H7.
    Sanchez-Villamil JI; Tapia D; Torres AG
    mBio; 2019 Aug; 10(4):. PubMed ID: 31409688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An approach to chimeric subunit immunogen provides efficient protection against toxicity, type III and type v secretion systems of Shigella.
    Felegary A; Nazarian S; Kordbacheh E; Fathi J; Minae ME
    Int Immunopharmacol; 2021 Nov; 100():108132. PubMed ID: 34508943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitosan-Based Intranasal Vaccine against Escherichia coli O157:H7.
    Doavi T; Mousavi SL; Kamali M; Amani J; Fasihi Ramandi M
    Iran Biomed J; 2016; 20(2):97-108. PubMed ID: 26724233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan nano-structure loaded with recombinant
    Khanifar J; Salmanian AH; Haji Hosseini R; Amani J; Kazemi R
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2593-2604. PubMed ID: 31240960
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunogenicity of a new recombinant IpaC from Shigella dysenteriae type I in guinea pig as a vaccine candidate.
    Malaei F; Hesaraki M; Saadati M; Ahdi AM; Sadraeian M; Honari H; Nazarian S
    Iran J Immunol; 2013 Jun; 10(2):110-7. PubMed ID: 23811550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenic Evaluation of Bivalent Vaccine Candidate against Enterohemorrhagic and Enterotoxigenic Escherichia coli.
    Karimi Rahjerdi A; Jafari M; Motamedi MJ; Amani J; Salmanian AH
    Iran J Immunol; 2019 Sep; 16(3):200-211. PubMed ID: 31552829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigate the immunogenic and protective effect of trivalent chimeric protein containing IpaD-StxB-TolC antigens as a vaccine candidate against S. dysenteri and S. flexneri.
    Fathi J; Amani J; Nazarian S; Hadi N; Mirhosseini SA; Ranjbar R; Abianeh HS
    Microb Pathog; 2023 May; 178():106066. PubMed ID: 36924900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with r-Lactococcus lactis expressing outer membrane protein A of Shigella dysenteriae type-1: evaluation of oral and intranasal route of administration.
    Yagnik B; Sharma D; Padh H; Desai P
    J Appl Microbiol; 2017 Feb; 122(2):493-505. PubMed ID: 27860045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction, characterization, and animal testing of WRSd1, a Shigella dysenteriae 1 vaccine.
    Venkatesan MM; Hartman AB; Newland JW; Ivanova VS; Hale TL; McDonough M; Butterton J
    Infect Immun; 2002 Jun; 70(6):2950-8. PubMed ID: 12010984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral immunization of mice with Lactococcus lactis expressing Shiga toxin truncate confers enhanced protection against Shiga toxins of Escherichia coli O157:H7 and Shigella dysenteriae.
    Sreerohini S; Balakrishna K; Parida M
    APMIS; 2019 Oct; 127(10):671-680. PubMed ID: 31344276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against shigellosis caused by Shigella dysenteriae serotype 4 in guinea pigs using Escherichia albertii DM104 as a live vaccine candidate strain.
    Chowdhury FM; Rahman MZ; Sarkar MMH; Rabbi F; Khan SI; Ahsan CR; Birkeland NK
    Acta Microbiol Immunol Hung; 2017 Jun; 64(2):151-164. PubMed ID: 28597684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model.
    Barry EM; Wang J; Wu T; Davis T; Levine MM
    Vaccine; 2006 May; 24(18):3727-34. PubMed ID: 16169130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal immunization with novel EspA-Tir-M fusion protein induces protective immunity against enterohemorrhagic Escherichia coli O157:H7 challenge in mice.
    Lin R; Zhu B; Zhang Y; Bai Y; Zhi F; Long B; Li Y; Wu Y; Wu X; Fan H
    Microb Pathog; 2017 Apr; 105():19-24. PubMed ID: 28163157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of immunogenicity and protective efficacy of orally delivered Shigella type III secretion system proteins IpaB and IpaD.
    Heine SJ; Diaz-McNair J; Martinez-Becerra FJ; Choudhari SP; Clements JD; Picking WL; Pasetti MF
    Vaccine; 2013 Jun; 31(28):2919-29. PubMed ID: 23644075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.